By Dr. Mercola Up to 50 million Americans struggle with acne, making it the most common skin disorder in the United States.1 When it strikes during the teen years, it can lead to feelings of self-consciousness, embarrassment and depression. Many severe acne sufferers struggle with low self-confidence, feelings of alienation and social withdrawal as a… Read More »
University of Delaware Professor Kristi Kiick is leading collaborative research to create new drug delivery systems with the potential to improve treatment for diseases that affect connective tissues, such as osteoarthritis or rheumatoid arthritis, which is an autoimmune disease. The UD researchers have devised tiny cargo-carrying systems many times smaller than a human hair. These… Read More »
A long-haired male golden hamster (via Wikipedia & Creative Commons) Earlier this week, a powerful opinion piece, “It Has Come To This: Ignore the CDC,” co-authored by former National Institutes of Health director Harold Varmus, was published in the New York Times. That’s on the science side. On the PR and journalism side, it has… Read More »
Read the Full Article for Free! You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access Unlock censored health information that Google doesn’t want you to read Keep your privacy secure — we… Read More »
Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »